The company will not receive any of the proceeds from the sale of the shares by the selling stockholder.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- Ekso Bionics’ Earnings Call: Growth Amid Challenges
- Ekso Bionics price target lowered to $1 from $2 at Lake Street
- Ekso Bionics: Strategic Partnerships and Financial Health Drive Buy Rating with $9 Price Target
- Ekso Bionics Reports Record Q4 Revenue and Strategic Partnership
- Ekso Bionics reports Q4 EPS (14c) vs. (22c) last year